Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex

Captopril is the first angiotensin I-converting enzyme inhibitor widely used for the treatment of hypertension. Based on the well-known benefits of cyclodextrin inclusion complexes, the present study investigated the ability of β-cyclodextrin to include captopril. Solid inclusion complexes of captop...

Descripción completa

Detalles Bibliográficos
Autores principales: Musuc, Adina Magdalena, Anuta, Valentina, Atkinson, Irina, Popa, Vlad Tudor, Sarbu, Iulian, Mircioiu, Constantin, Abdalrb, Ghaleb Abdalameer, Mitu, Mirela Adriana, Ozon, Emma Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464127/
https://www.ncbi.nlm.nih.gov/pubmed/32784691
http://dx.doi.org/10.3390/pharmaceutics12080744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464127/
https://www.ncbi.nlm.nih.gov/pubmed/32784691
http://dx.doi.org/10.3390/pharmaceutics12080744

Ejemplares similares